RA-led $35M round clears path for Cerebral’s epilepsy Phase II

Cerebral is looking to take its epilepsy drug delivery system into an international trial after proof-of-concept data for CT-010 enabled the company to raise a tranched $35

Read the full 272 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE